FattaLab® Fatty Liver Diagnostic Device

Non-invasive diagnostic equipment for gastrointestinal tract screening and disease detection in digestive system assessment.

Non-invasive diagnostic system designed for hepatic fibrosis assessment and screening. Enables early detection and monitoring of liver disease progression without tissue biopsy.

A diagnostic system developed using deep learning methods guided by physical theory principles to enable non-invasive detection of liver fibrosis. The system assists doctors and researchers in analyzing liver biopsy tissue samples.

An AI-powered diagnostic system utilizing deep learning algorithms to enable non-invasive detection and assessment of hepatic fibrosis. The system analyzes imaging data to provide quantitative fibrosis staging without requiring tissue biopsy.

Non-invasive screening and diagnostic device for hepatic disease detection and post-diagnostic management in liver disease assessment.

Non-invasive solution for accurate measurement of liver stiffness and steatosis assessment. Enables comprehensive management of liver disease through elastography technology with cloud-based data transmission for clinical workflow optimization.

CelTouch is a non-invasive imaging and diagnostic device for screening and diagnosis across multiple clinical specialties including hepatology, gastroenterology, pulmonology, breast, and urological applications. The technology enables early disease detection and post-diagnostic monitoring without invasive procedures.

A specialized diagnostic instrument for reading and interpreting lateral flow assay tests with cutting-edge technology. Delivers precise results across various medical and laboratory applications.

A diagnostic analyzer system utilizing digital holographic microscopy and AI technology for laboratory diagnostics. The system is designed for cell counting, viability assessment, urine microscopy, and turbidimetry and colorimetry applications. Fluidlab 1 represents anvajo's core diagnostic platform for human healthcare applications.

Non-invasive ultrasound-based device that measures liver stiffness and liver steatosis for comprehensive liver disease management. Utilizes transient elastography technology with SSM by VCTE™ for risk stratification and optimized measurement accuracy across all patient morphologies.

Fibroscan is a non-invasive and quantitative examination device for the liver, represented by Mediplast through Echosens. The device enables simultaneous examination for fibrosis and steatosis. It is available as an ultra-mobile model for quick and flexible screening outside the clinic.